340 related articles for article (PubMed ID: 23378843)
1. Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells.
Locatelli F; Pende D; Mingari MC; Bertaina A; Falco M; Moretta A; Moretta L
Front Immunol; 2013; 4():15. PubMed ID: 23378843
[TBL] [Abstract][Full Text] [Related]
2. Human natural killer cells: origin, receptors, function, and clinical applications.
Moretta L; Montaldo E; Vacca P; Del Zotto G; Moretta F; Merli P; Locatelli F; Mingari MC
Int Arch Allergy Immunol; 2014; 164(4):253-64. PubMed ID: 25323661
[TBL] [Abstract][Full Text] [Related]
3. Role of alloreactive KIR2DS1(+) NK cells in haploidentical hematopoietic stem cell transplantation.
Marcenaro E; Carlomagno S; Pesce S; Della Chiesa M; Moretta A; Sivori S
J Leukoc Biol; 2011 Oct; 90(4):661-7. PubMed ID: 21791599
[TBL] [Abstract][Full Text] [Related]
4. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity.
Pende D; Marcenaro S; Falco M; Martini S; Bernardo ME; Montagna D; Romeo E; Cognet C; Martinetti M; Maccario R; Mingari MC; Vivier E; Moretta L; Locatelli F; Moretta A
Blood; 2009 Mar; 113(13):3119-29. PubMed ID: 18945967
[TBL] [Abstract][Full Text] [Related]
5. Markers and function of human NK cells in normal and pathological conditions.
Del Zotto G; Marcenaro E; Vacca P; Sivori S; Pende D; Della Chiesa M; Moretta F; Ingegnere T; Mingari MC; Moretta A; Moretta L
Cytometry B Clin Cytom; 2017 Mar; 92(2):100-114. PubMed ID: 28054442
[TBL] [Abstract][Full Text] [Related]
6. Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.
Moretta L; Locatelli F; Pende D; Marcenaro E; Mingari MC; Moretta A
Blood; 2011 Jan; 117(3):764-71. PubMed ID: 20889923
[TBL] [Abstract][Full Text] [Related]
7. Human NK cells: From surface receptors to clinical applications.
Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT.
Sivori S; Carlomagno S; Falco M; Romeo E; Moretta L; Moretta A
Blood; 2011 Apr; 117(16):4284-92. PubMed ID: 21355085
[TBL] [Abstract][Full Text] [Related]
9. Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA; Denman CJ; Rondon G; Woodworth G; Chen J; Fisher T; Kaur I; Fernandez-Vina M; Cao K; Ciurea S; Shpall EJ; Champlin RE
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1290-1298. PubMed ID: 27090958
[TBL] [Abstract][Full Text] [Related]
10. Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.
Moretta A; Pende D; Locatelli F; Moretta L
Clin Exp Immunol; 2009 Sep; 157(3):325-31. PubMed ID: 19664139
[TBL] [Abstract][Full Text] [Related]
11. Identifying NK Alloreactive Donors for Haploidentical Hematopoietic Stem Cell Transplantation.
Ruggeri L; Mancusi A; Urbani E; Velardi A
Methods Mol Biol; 2016; 1393():141-5. PubMed ID: 27033224
[TBL] [Abstract][Full Text] [Related]
12. NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia.
Locatelli F; Pende D; Falco M; Della Chiesa M; Moretta A; Moretta L
Trends Immunol; 2018 Jul; 39(7):577-590. PubMed ID: 29793748
[TBL] [Abstract][Full Text] [Related]
13. Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.
Mancusi A; Ruggeri L; Urbani E; Pierini A; Massei MS; Carotti A; Terenzi A; Falzetti F; Tosti A; Topini F; Bozza S; Romani L; Tognellini R; Stern M; Aversa F; Martelli MF; Velardi A
Blood; 2015 May; 125(20):3173-82. PubMed ID: 25769621
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia.
Meazza R; Falco M; Loiacono F; Canevali P; Della Chiesa M; Bertaina A; Pagliara D; Merli P; Indio V; Galaverna F; Algeri M; Moretta F; Colomar-Carando N; Muccio L; Sivori S; Pession A; Mingari MC; Moretta L; Moretta A; Locatelli F; Pende D
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764469
[TBL] [Abstract][Full Text] [Related]
15. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
Ruggeri L; Capanni M; Mancusi A; Urbani E; Perruccio K; Burchielli E; Tosti A; Topini F; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2004; 33(3):216-21. PubMed ID: 15528134
[TBL] [Abstract][Full Text] [Related]
16. Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire.
Meazza R; Ruggeri L; Guolo F; Minetto P; Canevali P; Loiacono F; Ciardelli S; Bo A; Luchetti S; Serio A; Zannoni L; Retière C; Colomar-Carando N; Parisi S; Curti A; Lemoli RM; Pende D
Front Immunol; 2023; 14():1111419. PubMed ID: 36865545
[TBL] [Abstract][Full Text] [Related]
17. Alloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive Immunotherapy.
Ruggeri L; Parisi S; Urbani E; Curti A
Front Immunol; 2015; 6():479. PubMed ID: 26528283
[TBL] [Abstract][Full Text] [Related]
18. Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.
Vago L; Forno B; Sormani MP; Crocchiolo R; Zino E; Di Terlizzi S; Lupo Stanghellini MT; Mazzi B; Perna SK; Bondanza A; Middleton D; Palini A; Bernardi M; Bacchetta R; Peccatori J; Rossini S; Roncarolo MG; Bordignon C; Bonini C; Ciceri F; Fleischhauer K
Blood; 2008 Oct; 112(8):3488-99. PubMed ID: 18645039
[TBL] [Abstract][Full Text] [Related]
19. Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias.
Moretta A; Locatelli F; Moretta L
Immunol Rev; 2008 Aug; 224():58-69. PubMed ID: 18759920
[TBL] [Abstract][Full Text] [Related]
20. Human NK cells: from surface receptors to the therapy of leukemias and solid tumors.
Moretta L; Pietra G; Montaldo E; Vacca P; Pende D; Falco M; Del Zotto G; Locatelli F; Moretta A; Mingari MC
Front Immunol; 2014; 5():87. PubMed ID: 24639677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
